India · Delayed Price · Currency is INR Checkpoint Therapeutics Statistics
Total Valuation
BOM:531930 has a market cap or net worth of INR 405.87 million. The enterprise value is 388.90 million.
| Market Cap | 405.87M |
| Enterprise Value | 388.90M |
Important Dates
The last earnings date was Tuesday, August 12, 2025.
| Earnings Date | Aug 12, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
BOM:531930 has 9.29 million shares outstanding. The number of shares has increased by 0.09% in one year.
| Current Share Class | 9.29M |
| Shares Outstanding | 9.29M |
| Shares Change (YoY) | +0.09% |
| Shares Change (QoQ) | +0.07% |
| Owned by Insiders (%) | 28.58% |
| Owned by Institutions (%) | 4.99% |
| Float | 1.48M |
Valuation Ratios
The trailing PE ratio is 10.93.
| PE Ratio | 10.93 |
| Forward PE | n/a |
| PS Ratio | 0.16 |
| PB Ratio | 0.96 |
| P/TBV Ratio | 0.96 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 10.48 |
| EV / Sales | 0.15 |
| EV / EBITDA | 9.60 |
| EV / EBIT | 10.44 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.13 |
| Debt / EBITDA | 1.34 |
| Debt / FCF | n/a |
| Interest Coverage | 2.50 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 5.20% |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | 127.49M |
| Profits Per Employee | 1.86M |
| Employee Count | 20 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, BOM:531930 has paid 2.94 million in taxes.
| Income Tax | 2.94M |
| Effective Tax Rate | 7.34% |
Stock Price Statistics
The stock price has increased by +80.89% in the last 52 weeks. The beta is -1.13, so BOM:531930's price volatility has been lower than the market average.
| Beta (5Y) | -1.13 |
| 52-Week Price Change | +80.89% |
| 50-Day Moving Average | 39.03 |
| 200-Day Moving Average | 32.88 |
| Relative Strength Index (RSI) | 53.95 |
| Average Volume (20 Days) | 21,562 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BOM:531930 had revenue of INR 2.55 billion and earned 37.11 million in profits. Earnings per share was 3.99.
| Revenue | 2.55B |
| Gross Profit | 122.94M |
| Operating Income | 37.26M |
| Pretax Income | 40.05M |
| Net Income | 37.11M |
| EBITDA | 40.53M |
| EBIT | 37.26M |
| Earnings Per Share (EPS) | 3.99 |
Balance Sheet
The company has 71.15 million in cash and 54.18 million in debt, giving a net cash position of 16.97 million or 1.83 per share.
| Cash & Cash Equivalents | 71.15M |
| Total Debt | 54.18M |
| Net Cash | 16.97M |
| Net Cash Per Share | 1.83 |
| Equity (Book Value) | 421.74M |
| Book Value Per Share | 45.43 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 4.82%, with operating and profit margins of 1.46% and 1.46%.
| Gross Margin | 4.82% |
| Operating Margin | 1.46% |
| Pretax Margin | 1.57% |
| Profit Margin | 1.46% |
| EBITDA Margin | 1.59% |
| EBIT Margin | 1.46% |
| FCF Margin | n/a |
Dividends & Yields
BOM:531930 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.09% |
| Shareholder Yield | n/a |
| Earnings Yield | 9.14% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on December 20, 2022. It was a forward split with a ratio of 1.3333333333.
| Last Split Date | Dec 20, 2022 |
| Split Type | Forward |
| Split Ratio | 1.3333333333 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |